Join, Follow & Connect
Join Modern Healthcare's LinkedIn group Follow Modern Healthcare on Twitter Join Modern Healthcare's Facebook group Follow Modern Healthcare's Pinterest board Modern Healthcare's Flickr page Modern Healthcare's YouTube Channel Get a Modern Healthcare news feed

 
Comment Buy Reprints Print Article Share on LinkedIn Share on Facebook Share on Twitter Email this page to a colleague
Healthcare Business News
 

Covidien will buy Given in bid to expand GI imaging market


By Modern Healthcare staff
Posted: December 8, 2013 - 10:30 am ET
Tags:

Covidien announced late Saturday it will acquire Israel-based Given Imaging, which manufacturers ingested gastrointestinal imaging pills, for $30 a share or $860 million.

The offer, which must be approved by Given shareholders, represents a 27% premium over company's closing share price of $23.65 on Friday.

“We believe GI is one of the most attractive specialty procedure areas,” the Mansfield, Mass.-based Covidien, which is headquartered in Dublin, Ireland, said in its announcement. “Acquiring Given will enable Covidien to significantly expand its presence in a $3 billion GI market.”

Advertisement | View Media Kit

 

Given Imaging developed a camera-in-a-pill capable of visualizing, diagnosing and monitoring the digestive system. The 12-year-old technology represents a less invasive option than either endoscopy or colonoscopy, but hasn't gotten widespread acceptance in the market because it requires similar preparation for patients. The company now markets seven imaging systems for 21 separate GI conditions.

“The combination of Covidien's established global presence and Given Imaging's innovative capabilities has the potential to transform this market,” said Given CEO Homi Shamir. “After thoroughly evaluating our strategic options we determined that this transaction is in the best interests of Given Imaging, its shareholders and employees and provides unique benefits to patients globally.”

Covidien, a leading medical device and hospital supplies manufacturer with $10.2 billion in sales in 2013, estimated acquiring Given will add about $160 million to $200 million in annual sales. The company's major lines of business include wound dressings and sanitary napkins in its medical supplies division and bedside respirators and their monitoring systems in its medical device division.


What do you think?

Share your opinion. Send a letter to the Editor or Post a comment below.

Post a comment

Loading Comments Loading comments...

Search ModernHealthcare.com:


 

Switch to the new Modern Healthcare Daily News app

For the best experience of ModernHealthcare.com on your iPad, switch to the new Modern Healthcare app — it's optimized for your device but there is no need to download.